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Background/aim: Acne vulgaris (AV) is a chronic inflammatory skin disease that is common among adolescents. Its etiology involves
hormones, diet, genetics, and environmental factors. The aim of this study was to investigate the association between acne vulgaris and
insulin resistance (IR) and visceral adiposity index (VAI).
Materials and methods: The study included 184 individuals. Participants’ height, weight, waist and hip circumference and blood
pressure were measured. Morning fasting blood was obtained from all participants for measuring glucose, insulin, triglyceride (TG),
and cholesterol levels. The HOMA index and visceral adiposity index were calculated. The collected data were analyzed using statistical
methods.
Results: The patient and control groups exhibited similar age, gender, and body mass index (p > 0.05). There was no significant
difference between the patient and control groups in HOMA index and VAI (p > 0.05). A positive correlation was observed between
VAI and glucose, insulin, HOMA index, TG level, and waist circumference, whereas there was a negative correlation with high-density
lipoprotein (HDL).
Conclusion: Our study results demonstrated that IR and VAI were similar both in the AV and healthy control groups. There was no
correlation between acne severity score and waist circumference, glucose, insulin, TG, HDL, HOMA index, and VAI. These results
indicate that IR and visceral adipose tissue dysfunction alone are not effective in the development of acne.
Key words: Acne vulgaris, insulin resistance, visceral adiposity index

1. Introduction
Acne vulgaris is a common skin disease in adolescence,
varies by age, gender, ethnicity, and different geographical
regions. Its incidence is 64% in 20s, 43% in 30s and 3%–5%
in 40s. Approximately 20% of individuals with acne suffer
from the moderate and severe form of acne [1] . There are
four main mechanisms involved in the pathogenesis of AV:
follicular hyperkeratinization, increased sebum production,
Propionibacterium acnes colonization, and inflammation.
These mechanisms are believed to give rise to the disease
with the interaction of genetic susceptibility, diet,
environmental factors, hormonal and immune systems [2].
Androgens, growth hormones, and various growth factors
play a role in sebaceous gland growth and differentiation.
Insulin and insulin-like growth factor-1 receptors reside
on the surface of keratinocytes, which are involved in the

growth and differentiation of sebocytes and keratinocytes
[3]. Proinflammatory cytokines emerging under conditions
of chronic inflammation also cause IR and increase the
secretion of insulin by the pancreas. Elevated insulin levels
in adolescence lead to increased serum androgen levels
and stimulate sebum and keratinocytes in the skin, leading
to the development of acne lesions [3,4]. Previous studies
have shown that IR is associated with a higher incidence of
skin diseases such as acne, psoriasis, alopecia areata, and
vitiligo [4]. The VAI is a recently developed method that
accurately shows the amount of visceral adipose tissue. The
VAI, which is calculated using anthropometric measures
(waist circumference, body mass index (BMI)) and lipid
levels (TG, HDL), is an easy mathematical index with high
sensitivity and specificity in demonstrating gender-specific
visceral adipose tissue dysfunction [5].
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The aim of this study was to investigate the association
between acne vulgaris, a chronic inflammatory skin
disease, and VAI, an indicator of IR and visceral adipose
tissue dysfunction.
2. Materials and methods
The study was designed as a prospective cross-sectional
study evaluating the association between AV and IR
and VAI. The ethics committee approval was obtained
from Selçuk University Faculty of Medicine (2018/07).
A total of 92 patients diagnosed with moderate to severe
acne between 18–35 years of age who were admitted
to the dermatology outpatient clinic between January
2018 and December 2018 were included in the study.
A total of 92 healthy individuals without AV who were
admitted to the family practice center and dermatology
outpatient clinic were included in the control group. Acne
vulgaris and control group equalized in terms of age and
BMI. All participants were informed about the study in
accordance with the Declaration of Helsinki, and those
who agreed were included in the study with their signed
consents being obtained. Diabetes, hypertension, thyroid
disease, liver disease, endocrinological diseases (cushing
syndrome, acromegaly, congenital adrenal hyperplasia,
polycystic ovary syndrome (anamnesis and pelvic usg),
etc), smokers, and those who used isotretinoin, steroids,
and hormonal contraceptives were excluded from the
study. Similarly, since diabetes drugs can affect insulin
resistance, those who use diabetes drugs were not included
in the study. Participants’ height, weight, waist and hip
circumference and blood pressure were measured. BMI
was calculated by dividing the patient’s weight in kg by the
square of their height in meters. The Global Acne Grading
System developed by Doshi et al. was used to determine
the severity of acne [6].
The Global Acne Grading System divides seborrheic
areas into 6 parts: the right cheek, left cheek, nose, chin,
and chest and upper back. Each region is given a value
depending on severity (forehead = 2, right cheek = 2 left
cheek = 2, nose = 1, chin = 1, upper back and chest = 3)
and the local score is calculated by multiplying this value
by the lesion grade (no lesions = 0, comedones = 1, papules
= 2, pustules = 3, nodules = 4). Total score ranges from 0
(no acne), 1–18 (mild acne), 19–30 (moderate acne), 31–
38 (severe acne), and 39-44 (very severe acne).
Venous blood specimens were taken into the collection
tubes in the morning following 12 h of fasting for
biochemical and hormonal analysis. Blood specimens were
analyzed on the same day at the biochemistry laboratory
of hospital. Glucose was analyzed with the enzymatic
method on Beckman Coulter AU 5800 (Beckman Coulter,
Inc., CA 92821, USA). Total cholesterol, HDL cholesterol
and TG were analyzed with the enzymatic/colorimetric
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method on Beckman Coulter AU 5800 (Beckman Coulter,
Inc., CA 92821, USA). Insulin was analyzed with the
direct chemiluminescence method on Siemens Immulite
2000 (USA). IR was determined using the formula of
the HOMA index = (fasting glucose (mg/dL) × fasting
insulin (mIU/L)) ÷ 405. The HOMA index above 2.5
was considered IR [7]. The VAI was calculated using the
following gender-specific formulas.
For men; VAI = [Waist circumference ÷ (39.68 + (1.88
× BMI))] × (TG ÷ 1.03) × (1.31 ÷ HDL-cholesterol).
For women; VAI = [Waist circumference ÷ (36.58 +
(1.89 × BMI))] × (TG ÷ 0.81) × (1.52 ÷ HDL-cholesterol).
Waist circumference: cm; TG ve HDL-C: mmol/l.
The collected data were compared in the patient and
control groups. Additionally, multiple group comparisons
were performed between moderate and severe acne and
control groups.
Power analysis was performed using the GPower 3.1
software package. As a result of the power analysis, the
total number of observations required for 5% significance,
0.5 effect size and 85% power was determined as 146. Our
study was carried out with a total of 184 individuals. All
statistical analyses were performed using the Statistical
Package for Social Sciences for Windows version 22.0
(SPSS). The Kolmogorow-Smirnow and Shapiro-Wilk tests
were used to test whether the data conformed to normal
distribution. The student-t test was used for the normally
distributed data in the two group comparisons while the
Mann-Whitney U test was used for the nonnormally
distributed data. Multiple comparisons of parametric data
one-way analysis of variance (ANOVA) test was used.
Kruskal-wallis test was used to compare multiple groups
that did not show normal distribution. The chi-square test
was used for comparing the categorical variables. Multiple
comparison tests were not performed for nonsignificant
values as a result of ANOVA and Kruskal-Wallis tests. The
Pearson correlation was used to determine the relationship
between normally distributed data, whereas the Spearman
correlation analysis was used for nonnormally distributed
data. The data with normal distribution are presented as
mean standard error, whereas the data without normal
distribution are presented as median (25–75 quarter),
and categorical data as frequency. The value p < 0.05 was
considered statistically significant.
3. Results
The study was completed with a total of 92 AV patients
and 92 healthy controls. The patients and controls
exhibited similar age, gender, and BMI (p > 0.05). There
were no obese participants in the patient or control group.
Demographic characteristics of the participants are shown
in Table1.
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The HOMA scores exhibited similar results, with 1.749
(1.005–3.573) in the patient group and 1.78 (1.040–3.038)
in the control group (p = 0.704). There were 30 individuals
with IR in both the patient and control groups (p = 1.000).
The evaluation of the VAI scores revealed no significant

difference between the two groups, with the calculated VAI
score of 1.123 (0.792–1.538) in the patient group, and 1.075
(0.803–1.45) in the control group (p = 0.879) (Table 2).
Patients with mild acne were excluded from the
study. In the patient group, 50 (54%) individuals had

Table 1. Demographic characteristics of the participants.
Characteristics

Control group
(n = 92)

Patient group
(n = 92)

Pvalue

Age (year)

21 (19–23)

22 (19–25)

0.157 a

Women

80 (87%)

85 (92.4%)

Men

Gender n (%)

12 (13%)

7 (7.6%)

0.226 b

2

21.50 ± 0.26

21.17 ± 0.22

0.334 c

Less than 3000 TL

77 (83.7%)

81 (88%)

More than 3000 TL

15 (16.3%)

11 (12%)

Body mass index (kg/m )
Income n (%)

0.526 b

Parametric data were given as mean–standard error and nonparametric data were presented as median (25–75
quartile) and categorical variables were presented as a percentage. a Mann Whitney U, b Chi-square test, c Student–t
test.
Table 2. Comparison of data in the patient and control groups.
Control group
(n = 92)

Patient group
(n = 92)

Pvalue

Age (year)

22 (19–25)

21 (19–23)

0.157 a

Height (m)

1.65 ± 0.01

1.64 ± 0.01

0.114 b

Weight (kg)

59 (54–64.5)

56 (52–61.5)

0.092 a

BMI (kg/m )

21.50 ± 0.26

21.17 ± 0.22

0.334 b

Waist circumference (cm)

74 (68.5–79.5)

72 (68–78.5)

0.488 a

Hip circumference (cm)

92.5 (90–97)

93 (89–97)

0.861 ad

Waist/hip ratio

0.77 (0.74–0.83)

0.77 (0.75–0.81)

0.822 ad

Systolic blood pressure (mmhg)

110 (100–112.5)

105 (100–110)

0.198 a

Diastolic blood pressure (mmhg)

70 (60–75)

65 (60–70)

0.104 a

Triglyceride (mg/dL)

70.5 (56–91)

74 (53.5–102)

0.973 a

Total cholesterol (mg/dL)

159 (142–183)

158 (138.5–184)

0.834 a

HDL cholesterol (mg/dL)

51 (43–58)

51 (45–57)

0.578 a

LDL cholesterol (mg/dL)

91.2 (80.5–111.8)

89 (77.7–111.7)

0.542 a

Glucose (mg/dL)

82 (76.5–87)

82.5 (78–88)

0.280 a

Insulin (miu/L)

9.33 (5.27–14.5)

9.16 (4.98–17.6)

0.877 a

HOMA index

1.78 (1.040–3.038)

1.749 (1.005–3.573)

0.704 a

Visceral adiposity index

1.075 (0.803–1.455)

1.123 (0.792–1.538)

0.879 c

Insulin resistance n (%)

30 (32.6%)

30 (32.6%)

1.000 c

2

Parametric data were given as mean–standard error and nonparametric data were presented as median
(25–75 quartile) and categorical variables were presented as a percentage. a Mann Whitney U, b Student–t
test, c Chi-square test, d Hip circumference and waist-hip ratio of 149 participants were evaluated. BMI:
Body mass index, HDL: High-density lipoprotein, LDL: Low-density lipoprotein HOMA: Homeostasis
model assessment.
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moderate and 42 (46%) had severe acne. The three group
comparisons of the control, moderate, and severe acne
groups demonstrated no significant difference in IR (p =
0.590) and VAI (p = 0.947). Other parameters were similar
in all three groups. The VAI score was higher in those with
severe AV, but no statistically significant difference was
found (Table 3).
The correlation analysis of metabolic and
anthropometric measures revealed a positive correlation
between the VAI score and waist circumference, hip
circumference, HOMA index, insulin, glucose and TG,
and a negative correlation with HDL. A positive correlation
was observed between the HOMA index and BMI, insulin,
glucose and TG (Table 4). There was no correlation
between acne severity score and study parameters in the
patient group (Table 5).
4. Discussion
In the present study, a total of 92 individuals with moderate
to severe acne vulgaris and 92 healthy individuals in the

control group were compared in terms of IR and VAI.
Our literature review demonstrated that no study has
been conducted on VAI to date, which is accepted as an
indicator of cardiometabolic risk in patients with AV.
This is the first study in which IR and VAI were evaluated
together in the acne vulgaris and control groups. Our
study results demonstrated similar HOMA-IR and VAI
levels between patients with acne vulgaris and the healthy
control group. A positive correlation was found between
VAI and glucose, insulin, HOMA-IR, hip circumference.
Hormones play important role in the pathogenesis of
AV. Androgens, growth hormone, insulin and IGF-1 levels
increase in puberty [8]. Insulin and IGF-1 are known to
increase acne formation by increasing sebum production
and conversion of testosterone to dihydrotestosterone [9].
While some studies reported that individuals with AV had
high serum insulin and HOMA values, and there was a
weak positive correlation between acne severity score and
insulin and HOMA [10,11], other studies reported that
patient and control groups had similar serum glucose,

Table 3. Comparison of data between control group and acne severity groups.
Control group
(n = 92)

Moderate acne group
(n = 50)

Severe acne group
(n = 42)

Pvalue

Age (year)

22 (19–25)

21.5 (20–23)

20 (19–23)

0.241 a

Height (m)

1.65 ± 0.1

1.64 ± 0.01

1.64 ± 0.01

0.266 b

Weight (kg)

59 (54–64.5)

56 (52–61)

57 (52–62)

0.232 a

BMI (kg/m2)

21.62 ± 0.26

21.16 ± 0.29

21.17 ± 0.34

0.628 b

Waist circumference (cm)

74 (768.5–79.5)

70 (67–77)

75 (69–80)

0.232 a

Hip circumference (cm)

92.5 (90–97)

92 (87–96)

93 (89–99)

0.493ae

Waist/hip ratio

0.77 (0.74–0.83)

0.77 (0.75–0.8)

0.79 (0.76–0.84)

0.377 ae

Systolic blood pressure (mmHg)

110 (100–112.5)

105 (100–110)

105 (100–110)

0.424 a

Diastolic blood pressure (mmHg)

70 (60–75)

60 (60–70)

70 (60–70)

0,133a

Acne severity score

-

23.3 ± 0.36

33.24 ± 0.26

<0.05 d

Triglyceride (mg/dL)

70.5 (56–91)

70 (53–107)

75.5 (55–92)

0.996 a

Total cholesterol (mg/dL)

159 (142–183)

161 (145–183)

148 (130–184)

0.370 a

HDL cholesterol (mg/dL)

50.641 ± 1.072

52.920 ± 1.577

50.571 ± 1.393

0.402 b

LDL cholesterol (mg/dL)

91.2 (80–111)

91.7 (79.6–111.4)

88.2 (70–112)

0.616 a

Glucose (mg/dL)

82 (76.5–87)

82 (79–88)

83.5 (77–90)

0.499 a

Insulin (miu/L)

9.33 (14.5–5.27)

8.48 (4.86–14.8)

9.84 (5.1–19.7)

0.666 a

HOMA index

1.78 (1.040–3.038)

1.704 (1.056–3.234)

1.983 (0.982–4.335)

0.670 a

Insulin resistance n (%)

30 (32.6%)

14 (28%)

16 (38.1%)

0.590 c

Visceral adiposity index

1.075 (0.803–1.455)

1.111 (0.779–1.465)

1.134 (0.806–1.586)

0.947 a

Parametric data were given as mean–standard error and nonparametric data were presented as median (25–75 quartile) and categorical
variables were presented as a percentage. a Kruskal-Wallis Test, b ANOVA, c The Chi-square, d 92 people in the patient group were
evaluated and the student’s t-test was used to compare the acne severity in 2 groups. e Hip circumference and waist-hip ratio of 149
participants were evaluated. BMI: body mass index, HDL: high-density lipoprotein, LDL: low-density lipoprotein, HOMA: homeostasis
model assessment.
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Table 4. Correlation analysis between vai, insulin resistance, metabolic syndrome, and some anthropometric parameters in
the patient group.

VAI
BMI
HOMA
Weight

WC

BMI

HOMA

Insulin

Glucose

TG

HDL

HC

WHR

r

0.252

0.061

0.298

0.273

0.298

0.856

–0.446

0.260

0.162

p

0.015

0.564

0.004

0.009

0.004

<0.001

<0.001

0.019

0.149

r

0,500

1000

–0.008

0.003

–0.038

0.097

–0.044

0.582

0.191

p

<0.001

–

0.937

0.978

0.723

0.360

0.674

<0.001

0.087

r

0.298

–0.008

1000

0.992

0.335

0.263

–0.143

0.079

0.076

p

0.004

0.937

–

<0.001

0.001

0.011

0.175

0.483

0.498

r

0.579

0.828

0.022

0.023

0.046

0.039

0.004

0.639

0.176

p

<0.001

<0.001

0.832

0.830

0.537

0.713

0.973

<0.001

0.116

Spearman correlation analysis, VAI: visceral adiposity index, WC: waist circumference, HC: hip circumference, BMI: body
mass index, HOMA: homeostasis model assessment, TG: triglyceride, HDL: high-density lipoprotein, WHR: waist/hip ratio.

Table 5. Correlation analysis of parameters with acne severity
score in the patient group.
r

p*

Weight (kg)

0.021

0.844

Body mass index (kg/m2)

–0.082

0.440

Waist circumference (cm)

0.076

0.474

Hip circumference (cm)

0.012

0.915

Waist/hip ratio

0.104

0.355

Systolic blood pressure (mmhg)

–0.052

0.626

Diastolic blood pressure (mmhg)

0.080

0.449

Triglyceride (mg/dL)

–0.017

0.869

Total cholesterol (mg/dL)

–0.138

0.188

HDL cholesterol (mg/dL)

–0.079

0.456

LDL cholesterol (mg/dL)

–0.110

0.299

Glucose (mg/dL)

0.039

0.713

Insulin (miu/L)

0.057

0.591

HOMA index

0.047

0.659

Visceral adiposity index

-0.001

0.990

* Spearman correlation analysis, HDL: high-density lipoprotein,
LDL: low-density lipoprotein, HOMA: homeostasis model
assessment.

insulin and HOMA levels and there was no relationship
between acne severity score and insulin and HOMAIR [12–14]. In our study, we did not find any difference
between the patient and control groups in terms of
fasting glucose, insulin, and HOMA-IR. We did not find
any relationship between acne severity score and fasting
glucose, insulin, and HOMA-IR.

It was shown that adipokines and proinflammatory
cytokines secreted by visceral adipose tissue are
associated with chronic inflammation, IR, type 2 diabetes,
hypertension, and atherogenic dyslipidemia. Visceral
adipose tissue dysfunction increases the risk of mortality
of these diseases, independently of BMI [15]. VAI can be
used as a marker of visceral adipose tissue dysfunction,
which can be easily calculated using both anthropometric
measures and lipid levels [16]. Another study compared
waist circumference, BMI, waist-hip ratio, waistheight ratio, VAI, TG/HDL ratios in predicting 10-year
cardiovascular disease risk. It was emphasized that VAI is
the most sensitive parameter in predicting cardiovascular
disease risk. A significant relationship between VAI and
diabetes and hypertension were reported [17]. Similarly,
another study examining the relationship between VAI
with IR reported that the VAI score was significantly
higher in overweight and obese individuals with IR [18].
In our study, we found that VAI is related to weight, hip
circumference, HOMA-IR, glucose. Ji et al. examined
the relationship between VAI and HOMA-IR in adults.
They reported a significant positive relationship between
the HOMA-IR and VAI following the improvement of
waist/height ratio, waist/hip ratio and lipid parameters
in individuals with normal waist circumference, with
and without diabetes [19]. A positive correlation was
found between VAI and insulin and HOMA-IR [18,20].
The results of our study showed that there was a positive
correlation between VAI and hip circumference, HOMAIR, insulin, glucose; and a negative correlation between
VAI and HDL.
While past studies in the literature investigated only IR
in patients with AV, our study examined IR and VAI, which
is a very good marker in predicting visceral adipose tissue
dysfunction. The evaluation of the patient and control
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groups together along with the exclusion of those who
were smokers, who had the polycystic ovarian syndrome,
metabolic diseases, and those who used drugs that would
affect metabolism are among the strengths of our study.
The low number of men is the limitation of our study.
Our study results demonstrated that the frequency of
IR and VAI was similar in the acne vulgaris and healthy
control groups. No relationship was found between acne
severity score and waist circumference, glucose, insulin,
TG, HDL, HOMA-IR and VAI. These results suggest
that IR and visceral adipose tissue dysfunction are not
individually effective in the development of AV. Studies

involving acne patients with obesity and controls are
needed. In this regard, we believe that prospective studies
with broad exclusion criteria and a greater number of
participants should be conducted.
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